|
Name |
3,4-Dehydro-6-hydroxymellein
|
Molecular Formula | C10H8O4 | |
IUPAC Name* |
6,8-dihydroxy-3-methylisochromen-1-one
|
|
SMILES |
CC1=CC2=CC(=CC(=C2C(=O)O1)O)O
|
|
InChI |
InChI=1S/C10H8O4/c1-5-2-6-3-7(11)4-8(12)9(6)10(13)14-5/h2-4,11-12H,1H3
|
|
InChIKey |
OHHKDUWFPNAEHQ-UHFFFAOYSA-N
|
|
Synonyms |
3,4-Dehydro-6-hydroxymellein; 1204-37-1; 6,8-dihydroxy-3-methylisochromen-1-one; 1H-2-benzopyran-1-one, 6,8-dihydroxy-3-methyl-; 6,8-dihydroxy-3-methylisocoumarin; CHEBI:1369; CHEMBL559789; C03830; 6,8-Dihydroxy-3-methyl-1H-2-benzopyran-1-one; 6,8-dihydroxy-3-methyl-isochromen-1-one; 6,8-dihydroxy-3-methyl-1H-isochromen-1-one; AC1NQXBQ; Saccharonol A; SureCN1520526; MEGxm0_000264; SCHEMBL1520526; ACon1_002418; DTXSID50415064; ZINC6522158; BDBM50485548; NCGC00169867-01; BRD-K15024928-001-01-5; Q27105447; 6,8-Dihydroxy-3-methylisocoumarin, >=95% (LC/MS-UV)
|
|
CAS | 1204-37-1 | |
PubChem CID | 5280627 | |
ChEMBL ID | CHEMBL559789 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 192.17 | ALogp: | 2.1 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 66.8 | Aromatic Rings: | 2 |
Heavy Atoms: | 14 | QED Weighted: | 0.67 |
Caco-2 Permeability: | -4.76 | MDCK Permeability: | 0.00001120 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.992 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.801 |
30% Bioavailability (F30%): | 0.997 |
Blood-Brain-Barrier Penetration (BBB): | 0.063 | Plasma Protein Binding (PPB): | 87.28% |
Volume Distribution (VD): | 0.627 | Fu: | 15.61% |
CYP1A2-inhibitor: | 0.972 | CYP1A2-substrate: | 0.808 |
CYP2C19-inhibitor: | 0.179 | CYP2C19-substrate: | 0.063 |
CYP2C9-inhibitor: | 0.291 | CYP2C9-substrate: | 0.93 |
CYP2D6-inhibitor: | 0.451 | CYP2D6-substrate: | 0.609 |
CYP3A4-inhibitor: | 0.144 | CYP3A4-substrate: | 0.141 |
Clearance (CL): | 9.641 | Half-life (T1/2): | 0.828 |
hERG Blockers: | 0.024 | Human Hepatotoxicity (H-HT): | 0.098 |
Drug-inuced Liver Injury (DILI): | 0.85 | AMES Toxicity: | 0.095 |
Rat Oral Acute Toxicity: | 0.097 | Maximum Recommended Daily Dose: | 0.796 |
Skin Sensitization: | 0.894 | Carcinogencity: | 0.053 |
Eye Corrosion: | 0.821 | Eye Irritation: | 0.977 |
Respiratory Toxicity: | 0.304 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004676 | 1.000 | D04AIT | 0.371 | ||||
ENC005370 | 1.000 | D0K8KX | 0.361 | ||||
ENC001951 | 0.681 | D0FA2O | 0.349 | ||||
ENC002113 | 0.681 | D07MGA | 0.320 | ||||
ENC002933 | 0.653 | D07EXH | 0.319 | ||||
ENC004556 | 0.647 | D06GCK | 0.274 | ||||
ENC001569 | 0.647 | D0G4KG | 0.264 | ||||
ENC005393 | 0.579 | D0Y7PG | 0.260 | ||||
ENC002509 | 0.561 | D02UFG | 0.258 | ||||
ENC001940 | 0.560 | D0M8RC | 0.250 |